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Abstract
Background Uptake of colorectal cancer screening programmes
needs to be improved or at least maintained in order to achieve
projected reductions in mortality and morbidity. Understanding
the origins of non-participation in screening is therefore impor-
tant.
Objective To explore the beliefs and experiences of individuals
who had not responded either to their screening invitation or
reminder.
Design A qualitative study using in-depth interviews with non-
participants from England’s population-based colorectal cancer
screening programme. Data collection and analysis were carried
out using a grounded theory approach, with an emphasis on the
constant comparison method, and continued until saturation (27
interviews).
Findings The interviews provided an in-depth understanding of a
range of reasons and circumstances surrounding non-participation
in screening, including contextual and environmental influences as
well as factors specific to the screening test. Non-participation in
screening was not necessarily associated with negative attitudes
towards screening or a decision to not return a kit. Reasons for
non-participation in screening included not feeling that participa-
tion is personally necessary, avoiding or delaying decision making,
and having some degree of intention to take part but failing to do
so because of practicalities, conflicting priorities or external cir-
cumstances. Beliefs, awareness and intention change over time.
Discussion and conclusions A range of approaches may be
required to improve screening uptake. Some non-participants may
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already have a degree of intention to take part in screening in the
future, and this group may be more responsive to interventions
based on professional endorsement, repeat invitations, reminders
and aids to making the test more practical.
Background
Colorectal cancer (CRC) is the third most com-
mon cancer, and the second greatest cause of
cancer death in the UK, with over 41 000 new
cases and 16 000 deaths per year attributable
to CRC.1 The 5-year survival rate for CRC in
the UK is currently around 50%, and although
this is an improvement upon previous years, it
still represents one of the poorest rates in
Europe.2
CRC screening was introduced in England in
July 2006 and fully implemented by 2010.3 The
programme offers biennial guaiac faecal occult
blood test (FOBT) screening to men and
women aged 60–74 years. The guaiac FOBT
kit is completed at home and requires six stool
samples taken from three separate bowel
motions. Samples need to be collected before
they are contaminated with toilet water. Once
opened, the kit has to be completed and des-
patched for testing within 14 days.
Biennial FOBT screening has been shown to
reduce CRC mortality by 16%.4 If uptake of
60% is realized, it has the potential to prevent
20 000 deaths in the UK over the next
20 years.5 However, uptake during the first
28 months of the programme was only 54%6,
which is lower than other population-based
screening programmes in the UK, and needs to
be increased in order to achieve the projected
reductions in mortality.
FOBT screening uptake has been shown to
be considerably lower among some population
subgroups, including men, younger people, eth-
nic minorities and people with lower educa-
tional levels or living in areas of deprivation.6–9
Low uptake in CRC screening has also been
linked to low health literacy, health beliefs and
behaviours including cancer fatalism, psychoso-
cial factors such as lack of knowledge about
screening, underestimation of CRC risk and
negative perceptions of the screening test.7,10–13
In addition to the range of deliberative factors
associated with uptake of screening, there is
also recognition that intentions do not always
translate into action (the so-called ‘intention-
action’ gap). Among individuals who intended
to attend for flexible sigmoidoscopy, those who
failed to keep their appointment tended to
report higher pre-screening levels of life stress
and difficulty as indicated by socioeconomic
disadvantage and poor health.14 A variety of
interventions to improve uptake have been
studied, which have focused mainly on meth-
ods of invitation and follow-up, endorsement
by health professionals and supporting materi-
als. In general, these studies have reported
modest but discernible impacts on uptake.15–22
The aims of this study were to explore non-
participation in CRC screening to identify
potential mechanisms for improving uptake,
through an understanding of the beliefs, health
behaviours and decision-making processes of
those who did not respond to their FOBT
CRC screening invitation. Existing studies have
focused mainly on respondents who have taken
part in screening, different cancer sites or CRC
screening modalities or have reflected hypothet-
ical reactions to an invitation to screening.23–27
The focus of this study was on individuals who
were able to reflect on their actual decision-
making process and reasons for non-participa-
tion, rather than relying upon hypothetical
reactions to a screening invitation. Qualitative
methods were chosen to allow maximum
opportunity for exploration and inductive
hypothesis generation.
Methods
In line with principles of grounded theory,28
our sampling strategy was initially purposive
to achieve a maximal variation sample of
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Health Expectations, 18, pp.1645–1657
Colorectal cancer screening, N J Hall et al.1646
information-rich participants. Primary care
practices from the North East of England
mailed interview invitations to patients who
had not returned their FOBT screening kits, as
sent from the North East Hub of the screening
programme. We recruited through primary
care as we hoped that potential participants
would be reassured by the study being
endorsed by their GP practice and thereby
allow us to recruit ‘difficult to reach’ partici-
pants. We purposively over-sampled practices
serving areas of high deprivation and with low
screening uptake because we anticipated that
patients from these practices would be more
difficult to recruit and that their accounts were
likely to be of particular interest. Participants
who volunteered to be interviewed were then
selected to ensure variation in terms of age,
gender, GP practice and how many screening
rounds individuals had been invited to take
part in.
Interviews started with a general open-
ended question ‘Could you explain to me
your reaction when you received your invita-
tion to take part in screening?’ This allowed
general beliefs about the screening programme
to be elucidated and the participant to start
the interview by telling their ‘non-participa-
tion narrative’ without feeling judged. This
open ‘grand tour’ question enabled topics of
relevance to the interviewee to be followed
up, alongside other prompts covering beliefs
associated with the FOBT, CRC screening,
reasons for non-participation, perceived barri-
ers to participation and potential mechanisms
for improving uptake. Transcripts were coded
following the principles of grounded theory.
Initial categories were identified by coding
each transcript line by line. These categories
were then developed and refined into more
general codes by relating categories to each
other. Transcripts were coded by a second
researcher. Where there were discrepancies,
categories were compared and discussed until
consensus was reached. The constant compar-
ative method was used to ensure that atten-
tion was paid to negative cases as well as the
differences and similarities between accounts.28
Recruitment continued in three phases until
sufficient accounts were obtained to enable
maximum comparison of the themes identified
during data collection and that additional
data no longer revealed new categories or
insights about existing ones.
The reply slip from the invitation to take
part in the study included a section to allow
those who did not wish to be interviewed to
state their reasons for not taking part in
screening. These responses were analysed sepa-
rately and compared to the themes emerging
from the main qualitative analysis.
Results
Individuals from 15 family practices (n = 923),
who had not responded to their invitation(s) to
take part in the CRC screening programme,
were mailed an invitation to take part in the
study. Of these, 35 agreed to be interviewed, of
whom 27 were selected for interview. A further
32 declined interview but provided written rea-
sons for their non-participation in the screen-
ing programme. A separate analysis based on
these comments confirmed that we had sam-
pled a full range of accounts within the main
interview data in terms of reasons for non-
participation in screening.
Interviewees (14 women and 13 men) varied
in terms of working status, number of times
invited for screening, reasons for non-participa-
tion and socio-economic status. A quarter of
our interviewees lived within areas belonging to
the most deprived quintile in England (based on
ranked scores of indices of multiple depriva-
tion); however, our sample also included three
interviewees from the least deprived quintile.
Ages ranged from 60 to 72 years. None were
from an ethnic minority group.
Intention and decision making
Despite none of our interviewees having
returned a kit, accounts demonstrated wide dif-
ferences in reported intention to take part in
screening. Only 10 interviewees had not
intended to take part in screening, 10 intended
© 2013 John Wiley & Sons Ltd
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to take part and seven had put off making a
decision.
A previous decision or lack of decision to
take part was not always reflective of future
intention or decision making. Processes could
change over time and differ between the rounds
of invitations sent biennially by the pro-
gramme. For example, some interviewees, who
had decided that screening was appropriate for
them, showed an increased strength in inten-
tion to take part in the next round after having
had time to consider the practicalities and
implications of returning a kit and because of
their awareness that a previous screening round
had been missed.
I don’t think I went beyond having a quick
glance at the first pack.. when the next one came
I was determined to do something about it.. it
may be by the time you get the third request,
you’re in gear, you know in terms of prepared
for it and organised for it (B15, male, 62 years).
For others, however, having considered par-
ticipation the first time round and decided
against it meant that less or no consideration
was required upon receipt of the second invita-
tion.
It was a quicker decision the second time. The
first time I did think about it.. the second time I
didn’t (B13, female, 66 years).
Although the majority of interviewees
reported some degree of intention to partici-
pate in screening if invited again, three said
that they would not consider future participa-
tion. One interviewee felt she may reconsider if
the sampling procedures were changed.
Figure 1 illustrates the differences between
interviewees in reported decision making and
level of intention to take part at the time of
their screening invitation and includes examples
of related contexts surrounding non-participa-
tion within these categories. This helps to
Put to one side 
“I just opened the packet, 
put the packet down and 
thought    I’ll get round to 
thinking about it, but as yet 
I’ve never got round to it” 
(B14, male, 60 years)
Level of decision making
No intention to take part
Reported decision made No decision made either way
Screening not necessary
“The pack came through and I did 
read it, you know and I think it was 
you know wonderfully done, 
wonderfully explained and 
everything else but I thought this 
really isn’t for me” (B17,  Male, 60 
years)
Not able to do it now
“ I was having some neurological 
problems and prostate, and I was 
thinking I don’t really want to get 
into this really, I want to get myself 
sorted out first, you know, before”.. 
(B6, male, 62 years)  
Circumstances beyond control
“I was really geared up to do it, then 
the postal strike and my mother’s 
death and well I didn’t know which way 
was up, so that torpedoed that one 
basically” (B11, male, 66 years)
Forgot
”.. But this time I was just full of good 
intentions.  I even took the stuff 
upstairs,  But by the time I 
remembered, and that’s the problem 
you know you don’t remember that’s 
the big thing” (B12, female, 62 years)
Intention to take part
Level of intention to take part
No decision made
Figure 1 Variation in decision making and intention to take part at invitation, including examples of non-participation.
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demonstrate that non-participation in screening
is not necessarily due to an uninformed deci-
sion-making process or a lack of understanding
of the value of screening.
A range of difficulties and reasons for non-
participation were described by the intervie-
wees. These ‘barriers’ occured at both the deci-
sion-making stages as well as subsequent to a
decision or intention to take part. For example,
‘other health priorities’ were cited as a reason
to avoid decision making, deciding not to take
part, and as a barrier for those who had
already intended to participate (See Table 1).
Influences on screening behaviour that were
identified in the interviews are summarized in
Table 2. They included psychosocial factors
(knowledge, attitudes, beliefs, emotions and the
influence of others), contextual factors (con-
flicting demands and life events, recent health-
care monitoring) and test-specific factors (the
practicalities of the sampling requirements and
distaste for the FOBT).
Psychosocial influences
The importance of cancer screening and early
detection was recognized by almost all intervie-
wees. Screening for CRC, specifically, was
viewed by all but one interviewee as a ‘good
thing to do’, a ‘good opportunity’ and a worth-
while use of NHS resources.
I’m totally convinced of its necessity in the sense
that if you’re offered something that can save
your life, you’re stupid to turn it down (B11,
male, 66 years).
Positive attitudes towards screening, in prin-
ciple, were reported even by those who believed
that screening was unnecessary for them per-
sonally, whether due to recent medical investi-
gations or procedures, feeling ‘well’ and not
experiencing bowel symptoms, or a preference
to rely on symptom detection. Interviewees
who had intended to take part often struggled
to reconcile their beliefs about the importance
of screening with their own non-participation.
Some found their non-participation in screen-
ing more difficult to rationalize than others,
and for some, was associated with feelings of
guilt. Study participants varied widely in their
levels of health literacy. Although we did not
specifically request occupational information,
interviewees volunteered this information
within their accounts as they felt it helped to
explain their attitudes towards screening, par-
ticularly for those who were currently or previ-
ously employed as health professionals,
including two who had cared for patients with
CRC. Many interviewees, particularly the
women, were keen to impress that they took
care of their health and were regular attenders
for other health and screening checks.
Most interviewees reported a perceived lack
of knowledge about the condition. This was
the case even among those who had friends or
relatives with a CRC diagnosis. Specific aware-
ness of the programme was low, and only five
of the interviewees had some prior knowledge
of it when they had received their first kit in
the post. Interviewees commented that it had
arrived ‘out of the blue’ or they had been
surprised at both having received the invitation
to take part as well as the procedures that they
were being asked to undertake, which were
often described as ‘unfamiliar’ or ‘alien’. The
people we spoke to would have received their
first invitation to take part in screening during
Table 1 Other health priorities as a barrier to participation
– example of differences in timing of influence
Other health priorities as a barrier prior to decision making
it’s just when you’re in pain all the time these things
don’t seem to matter. I know they do matter… I just
didn’t want to find anything else wrong, head in the sand
you know, I just put it to one side and forgot about it to
be perfectly honest with you (B16, female, 64 years).
Other health priorities as a barrier during decision making
there’s so many things going on, you know, I have to see
a hematologist and I have to see the prostate guy and
then the urologist which is slightly different. And I’m
thinking well, you know, I don’t, I just don’t want to get
involved in this (screening)’ (B6, male, 62 years).
Other health priorities as a barrier after decision making
I was well up for it you know, it was just I was just about
to do it and then I was rushed into hospital’ (B5, Male,
60 years).
© 2013 John Wiley & Sons Ltd
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the very early phases of the screening pro-
gramme in England. Awareness of the screen-
ing programme was reported to be increasing
over time. Although all our interviewees should
have received a letter 2 weeks before their kit
arrived advising them this was going to be
received, this was rarely mentioned or remem-
bered. Those who described receiving a warn-
ing letter still felt unprepared for what was
being asked of them when the kit had arrived.
Accounts showed variation in the level of
personal reflection and consideration of the con-
sequences of taking part in screening. When
they were considered, these centred not only on
Table 2 Summary of barriers to participation
Theme Open codes
Knowledge, beliefs and awareness Lack of awareness of others who have taken part (social norms difficult to assess)
Perceived low awareness of bowel cancer generally and screening programme
specifically
Preference to go to GP with symptoms/belief that screening more necessary
if symptoms apparent
Belief that treatment is likely to be unsuccessful or that bowel cancer is untreatable
Perception that screening is not personally needed (e.g. lack of symptoms, feeling well)
Unrealistic optimism/low perceptions of risk
Age-related beliefs (e.g. decreased ability to fight off illness with age)
Perception that it is better not to know (e.g. when there is no interest
in receiving treatment)
Traditional male gender roles and beliefs regarding health care and related activities
Bowels are private and not discussed
Belief that rectal bleeding (haemorrhoids or IBD) will affect test results
Emotional reactions to invitation Disgust/distaste at dealing with faeces
Avoidance of decision making (put at back of mind or ignored)
Anxiety and fear about susceptibility, potential cancer diagnosis,
further testing and hospitals
Unable to ‘cope’ with additional demands (e.g. due to depression,
illness, stressful life events)
Embarrassment/difficult topic to discuss
Lack of need for reassurance
Circumstances Other more pressing priorities, (stressful life events, health concerns
and illness, caring for others) or not prioritising own health
Not wanting to waste resources by completing kit unnecessarily
Previous negative experiences of health care and health-care system
Recent GI medical intervention Recent colonoscopy or other surveillance procedure
Recent bowel cancer diagnosis
Ongoing monitoring or medical review for bowel condition (e.g. IBD)
Practicalities of completing kit Perceived complexity of sampling procedures
Disgust/distaste at dealing with faeces
Lack of understanding of information provided
Unfamiliarity of taking own samples
Inability to take sample due to disability
Need for contemplation, planning and organization
Lack of confidence in being able to carry out sampling procedures
Lack of understanding of whether/when screening is appropriate when
under medical review, or recent endoscopy investigations taken place
Not having read the information thoroughly or at all
Practicalities associated with going to the toilet, for example where and
when bowel movements take place, regularity of bowel movements
Test seen as unable to provide definitive answer re: cancer diagnosis
Concerns about hygiene (storage, disposal of equipment and posting)
© 2013 John Wiley & Sons Ltd
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the benefits of early detection, but also on more
negative potential consequences such as antici-
pated anxiety associated with waiting for and
receiving results, fear of a potential cancer diag-
nosis, and fear or avoidance of further testing
treatment and hospital visits. The potential need
for a colonoscopy after FOBT provoked anxiety
and specifically acted as a deterrent for some in-
terviewees. Consideration of the consequences
of screening was, nevertheless, not always asso-
ciated with a lack of intention to take part. This
was often rationalized as part of a normal deci-
sion-making process, involving natural anxiety
over the contemplation of an intrusive test and a
potential cancer diagnosis alongside the benefits
of early detection.
They’re not the nicest of tests to have I believe
(endoscopy), if they did say ‘come back there is a
problem,’ I would get very anxious about having
those tests done, there’s no doubt about it but
you’ve got to do these things haven’t you? (B25,
female, 67 years).
Influence of others
Accounts demonstrated how others had influ-
enced interviewees’ decision making or future
intention by, for example, changing associated
beliefs or social norms in relation to screening
behaviour. This occurred in a number of ways,
including: personal experience of friends and
relatives diagnosed with bowel cancer; aware-
ness of others invited or who had taken part in
screening; and encouragement (or lack or)
from family and friends.
we heard of a dear friend who has been picked
up as having bowel polyps as a result of this
screening, so I was completely reinforced in the
urgency and necessity of all of this and have no
question about it at all, in principle (B11, Male,
66 years).
One interviewee described how her own
CRC diagnosis, subsequent to her non-partici-
pation in screening, had prompted her neigh-
bour to request another screening kit.
The perceived social acceptability of talking
about CRC with others was an important sub-
theme in this area. Cancer was a topic that was
felt to be difficult and frightening to discuss
generally. There was acknowledgement, never-
theless, that this was more openly discussed
than it used to be, particularly among the age
group involved in screening. Health concerns
could also be discussed more openly with age,
particularly for the men. Public awareness
about CRC was perceived to be lower than for
other more ‘common’ cancers. Breast and cer-
vical cancer, in particular, were most com-
monly and openly discussed by the women,
usually in the context of screening, as was
prostate cancer by the men.
so in a blokey, jokey kind of way, that (prostate
cancer) is something that you, well not so much
discuss as, it’s a kind of male acknowledgement
that it’s going on,.. but we can make a joke of it
and have another pint, but I don’t think that
would be the case for bowel cancer (B11, male,
66 years).
The practical requirements of completing
and returning a kit, and bowels or bowel
movements, were perceived as embarrassing
and difficult to broach. Embarrassment and
reluctance to talk to others in the household
about the screening process was a problem
for some, particularly as completion of the
kit, which includes storage and disposal of
equipment, is difficult to carry out in a totally
private manner. On the other hand, screening
was also viewed to be possibly beneficial as it
could help to avoid future embarrassment
associated with having to consult a GP with
symptoms.
None of the people we spoke to had dis-
cussed their participation in screening with a
health professional, even those who reported
having contact for other reasons around the
time of their invitation, and this included indi-
viduals who were unsure about their need to
take part. Neither had they considered their
need for information sufficient enough to con-
tact the screening hub for advice. Some inter-
viewees suggested, however, that they may
have taken part in screening if they had been
advised to do so by their doctor and saw their
© 2013 John Wiley & Sons Ltd
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family practice as an appropriate place for
screening-related activity. Being able to hand
in completed kits or collect additional
resources or equipment to help with sampling
procedures from their local surgery are exam-
ples of some of the suggestions provided.
Contextual influences
Conflicting priorities or events were the most
commonly mentioned ‘reasons’ for not having
returned a kit among those who had not
actively decided against taking part. Other
health priorities included acute and chronic
health conditions as well as mental health
issues and health or cancer ‘scares’. Addi-
tional influences were associated with stressful
life events, such as bereavement, caring for
others, work or other time pressures. These
became barriers to participation when the
individual felt unable to manage additional
pressure or demands, were unable to physi-
cally manage the requirements of screening
procedures, for example during a flare-up of
arthritis, or when they did not have easy
access to the kit because of life events. The
perceived complexity and unfamiliar nature of
the procedures required to participate in
screening, which are discussed in more detail
below, became more of a barrier at these
times. One interviewee, for example, described
how mild depression and dealing with stress-
ful family events had meant she had not
felt capable of taking in the information pro-
vided despite her positive attitudes towards
screening.
Yeah, I mean normally I cope with things, and
then when I saw that (screening invitation), and
it was just let’s be honest, I’m not going to blame
anything other than myself because I could have
sat down and just given it half an hour to work
out what I had to do. But I didn’t. …when I
opened it all up I thought god this looks compli-
cated, and I didn’t really read it properly’
(B24, female, 62 years).
Arrival of the screening kit at a ‘bad time’
was usually associated with delayed decision
making, or a decision not to take part at that
particular time, rather than an intention not to
take part in screening at all.
Test-specific influences
Interviewees’ accounts demonstrated that the
processes involved in collecting stool samples
required a certain amount of planning and
consideration. Most interviewees who had
intended to complete their kit described ‘men-
tally rehearsing’ these processes, but many did
not feel at all confident in their ability to com-
plete their kit correctly. Commonly mentioned
issues included suitable equipment to catch the
stools with, avoidance of contamination with
toilet water, hygienic disposal of any equip-
ment used, storage of the kit and having
required equipment when and where it was
needed.
I thought about it and then I thought, I can’t
practically do this at work. You know, I mean
the mechanics would be sort of putting newspa-
per or something in the toilet bowl and taking
the sample from there and then you’ve got to
dispose of the newspaper which wouldn’t be a
problem at home (B15, male, 62 years).
Other practical concerns related to the time
required to take each sample, remembering to
complete the kit and completing all the samples
within the required time frame. Women, in
particular, compared the process to other
screening programmes which were perceived to
require less ‘consideration’ and preparation.
It’s not like your smears or mammograms or
anything like that. You get an appointment you
do it and that’s a lot easier.. you go, you get it
done, that’s it.. This is actually having to orga-
nise yourself and I think that’s more difficult….
You can almost join in the rest of the screening
programmes quite mindlessly if you know what I
mean. (B12, Female, 62 years).
Interviewees who had recently undergone
colonoscopy or had had a recent bowel cancer
diagnosis demonstrated some confusion over
whether or when they needed to complete a
screening kit and how to ‘opt out’ of the
screening process. There was, in particular, a
reluctance to waste health-care resources by
© 2013 John Wiley & Sons Ltd
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completing kits unnecessarily or appear to be a
‘bad patient’ by not responding to their invita-
tion.
Distaste, embarrassment and hygiene con-
cerns associated with having to deal with faeces
were mentioned by everyone interviewed. The
majority, however, did not feel this was a major
concern and were keen to highlight that it had
not been the main reason for their non-partici-
pation. For most interviewees the procedures
involved in providing three samples in a hygie-
nic manner, including disposal of equipment
needed and storage of samples, was more prob-
lematic than the distaste of dealing with faeces
per se. Some, however, did report that ‘distaste’
was a particular problem, and four interviewees
reported this had been the main reason for their
non-participation. For a minority of partici-
pants, hygiene concerns about putting the sam-
ples in the post were also off putting.
Discussion
This study provides in-depth insights into the
perspectives of non-participants in the English
CRC screening programme. These individuals
were uniquely able to reflect upon their actual
decision making and actions taken in response
to their screening invitation. We found that
non-participation is not necessarily associated
with negative attitudes towards screening or a
decision to not return a kit. Individuals who
do not participate on any one round have a
range of reasons, including not feeling that
participation is personally necessary (which in
some cases would be viewed as medically justi-
fied, for example, those who have had a recent
colonoscopy prior to their screening invita-
tion), avoiding or delaying decision making,
and having some degree of intention to take
part but failing to do so because of practicali-
ties, conflicting priorities or external circum-
stances.
Attitudes towards the FOBT and required
sampling procedures were varied, but a com-
mon theme was low confidence in the ability to
carry out the required sampling procedures.
The test was consistently seen as distasteful,
inconvenient, embarrassing to discuss and
unhygienic, although many interviewees made
clear that this had not been the primary barrier
to participation.
Our result extends findings from a previous
interview study on experiences of screening and
decision making23 by including perspectives
from a wider sample of non-participants with
variation in their reasons for non-participation,
socio-economic status, number of invitations,
gender and beliefs about their own need for
screening. Other qualitative research in the
UK, although of relevance, has been based on
flexible sigmoidoscopy screening or has focused
on intention and decision making rather than
actual participation,25,26 and the transferability
of findings from other countries,29 or screening
programmes, is not always clear.
We had anticipated from the outset that this
would be a difficult group of respondents to
recruit. Every effort was made to ensure that
the invitation to take part in the study pro-
vided assurances that the study researchers
would be objective and non-judgmental and
would not be making any screening-related rec-
ommendations. As this was a qualitative study,
we were not aiming to achieve representative-
ness, but to gain an understanding of the
contexts, processes and meanings attached to
non-participation in bowel cancer screening in
a sample of volunteers who were able to reflect
upon their actual decision making and actions
taken in response to their screening invitations.
The low response to our invitation to partici-
pate could, however, be argued to represent a
potential bias in the type of respondents we
were able to include, with those with negative
attitudes to screening or who find the topic
embarrassing to discuss being less likely to take
part in our study, for example. The accounts
from the people we spoke to, nevertheless,
seem to have been open and honest and dem-
onstrated varying degrees of difficulty and
embarrassment when talking about bowels,
bowel movements and their personal experi-
ences of cancer. Variation was also evident in
their reasons for non-participation, decision
making and intention to take part, despite their
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non-participation, and even for those with gen-
erally positive attitudes towards cancer screen-
ing in principle. High levels of positive
attitudes towards screening in principle have
been reported by others.24–26,30,31 For example,
in a UK quantitative survey,31 only 1.1%
reported they would be definitely not interested
in taking part in FOBT screening, demonstrat-
ing generally positive attitudes which are not
reflected in actual uptake. Despite limitations,
our findings allow useful insights into decision-
making processes and behaviours which are
currently not well understood and which would
otherwise be difficult to obtain.
Further quantitative research would be
required to ascertain the proportion of non-par-
ticipants who may benefit from the suggestions
for improving uptake from our interviewees
and analysis, the frequency of reasons for non-
participation within this population and the
views of people from ethnic minority groups
who are reported to have lower uptake rates
and who were not represented in this study.
Confidence in our findings is further
strengthened by the fact that all the reasons for
non-participation in screening provided to us
by respondents declining interview emerged
unprompted within the interviews and that our
findings allow elaboration of themes identified
in other qualitative and quantitative stud-
ies,23,24,30–35 including, for example, an appreci-
ation of a ‘public responsibility’ to participate
in population screening programmes and a
reluctance to be seen as using NHS resources
inappropriately, both attitudes that have been
reported by others.23,24 In addition, however,
our findings also showed that many of the rea-
sons provided for taking part in screening,
such as positive experience of women’s screen-
ing programmes and encouragement from
others,23 are also reported by those who do
not return a kit. As would be expected, our
findings confirm the relevance of concepts from
existing models of health behaviour within this
setting and their potential as a foundation for
interventions to improve uptake.27,34–37
Interviewees who held strong beliefs about
the importance of screening or described more
‘emotional’ responses to the screening request
tended to find ‘rationalising’ their non-participa-
tion during the interview more difficult and
often reported a degree of guilt or self-blame for
not having taken up the opportunity of screen-
ing provided to them. Available information or
existing knowledge about risks and benefits of
screening, when taken into account at all,
appears to be considered in the light of other
influences, including wider social contexts,
practicalities and pressures of daily life. This
reflects the conclusion from previous work that
‘informed choice’ in the context of screening is
conceptualized differently by lay people and pol-
icymakers.32 Although lack of knowledge and
understanding have a role in decision making
and screening uptake,12,31,38 our findings indi-
cate that these factors are not sufficient. Similar
conclusions were reached in a study from the
United States,39 and studies from Germany and
Australia have shown that interventions to
improve informed choice had either no effect or
a detrimental one on uptake.32,40
Improved understanding and information
may be beneficial, however, to ensure that peo-
ple’s decisions to take part in CRC screening
are not based on the presence or absence of
bowel symptoms. There may also be a related
concern that people who do proceed to screen-
ing and have a negative screening test result
may then dismiss symptoms that develop later,
an issue which is the subject of a current Can-
cer Research UK funded project.
In contrast to a prevailing view that better
information is key to improving uptake, the
most commonly mentioned suggestions from
interviewees in this study related to practical
issues, including the provision of different kits
or aids to help collect (and in particular catch)
their stool with and avoiding contamination
with toilet water. Timing was also an issue.
Other types of FOBT kits exist, which require
fewer samples or allow the stool to be sampled
in the toilet water. Different test requirements
may have helped at least some of the people
we spoke to overcome their lack of confidence
in providing a sample correctly and in a hygie-
nic manner. Other studies have also identified
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a preference for, and higher participation rates
with, an immunochemical FOBT, which
requires only one sample, compared to the
gFOBT.29,41–43 Simplifying the test require-
ments could also benefit uptake by helping to
minimize the impact of other inevitable and
conflicting priorities and life events on screen-
ing behaviour.
The majority of our interviewees had not
expected to receive their invitation and described
it as arriving ‘out of the blue’ or ‘an invasion of
privacy’. Some suggested that more warning and
time to consider the practicalities of sampling
would have been beneficial. Findings from the
Netherlands suggest that sending an advance
notification letter significantly improves
uptake,44 yet the letter sent prior to the kit by the
screening programme was very rarely remem-
bered or referred to during our interviews.
None of our interviewees had discussed par-
ticipation with a health professional, although
there were indications that some may have
been more inclined to take part if they had
been advised to do so by their doctor. This is
consistent with findings from a recent trial
which demonstrated that endorsement letters
from GPs and enhanced procedural leaflets
could increase uptake by 10%.18
Conclusions
A range of different approaches may be
required to improve uptake in CRC screening
depending on the experiences, circumstances,
beliefs and existing levels of intention of non-
participants. Our findings show that some
individuals who do not participate in CRC
screening have a positive attitude to screening
in principle and may already have a degree of
intention to take part despite not having
responded to previous screening invitations.
Interventions are needed that can help convert
this intention into action. Focusing solely on
the way information is presented is unlikely to
be productive in this group. These individuals
are more likely to respond to professional
endorsement, repeat invitations, reminders and
aids to making the test more practical. Chang-
ing the screening test to one with simpler sam-
pling requirements could reduce the perceived
barriers at the decision-making stage as well as
the actual difficulties encountered, thus mini-
mizing the inevitable impact of conflicting pri-
orities and life events.
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